Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
09/2008
09/12/2008WO2008109584A1 Hcv ns5b inhibitors
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008108988A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections
09/12/2008WO2008107418A1 Fused pyrimidinone compounds as mglur ligands
09/12/2008WO2008107064A1 New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6h)-one
09/12/2008WO2008106715A1 Oxazinyl isoflavonoid compounds, medicaments and use
09/12/2008WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/12/2008CA2680312A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2680177A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2679657A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections
09/12/2008CA2679619A1 New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6h)-one
09/12/2008CA2679580A1 Oxazinyl isoflavonoid compounds, medicaments and use
09/12/2008CA2678463A1 Fused pyrimidinone compounds as mglur ligands
09/12/2008CA2678100A1 Bicyclic oxomorpholine derivative
09/11/2008US20080221149 Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709
09/11/2008US20080221091 Metalloprotease inhibitors containing a heterocyclic moiety
09/11/2008US20080221090 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid
09/10/2008EP1967520A2 Production of polyketides and other natural products
09/10/2008EP1966221A1 Pyrimido- [4, 5-]-oxazines for use as dgat inhibitors
09/10/2008EP1966219A1 Process for the preparation of s-(+)-clopidogrel by optical resolution
09/10/2008EP1966203A2 Oxazoloisoquinoline derivatives as thrombin receptor antagonists
09/10/2008EP1735308B1 Fused ring azadecalin glucocorticoid receptor modulators
09/10/2008EP1284978B2 Process for the purification of a salt of clavulanic acid
09/10/2008CN101260115A Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation
09/10/2008CN101260114A Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation
09/09/2008US7423152 Process for the manufacture of intermediates in camptothecin production
09/09/2008US7423048 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release
09/04/2008WO2008106139A1 Inhibitors of serine proteases for the treatment of hcv infections
09/04/2008US20080214807 Combat pain and display outstanding affinity to the subtype 1 vanilloid receptor (VR1/TRPV1 receptor); [1] 3-[4-(3-chloropyridin-2-yl)piperazine-1-carbonyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8-carboxylic acid-(2-fluorophenyl)amide; cardiovascular, eating disorders; medication dependency
09/04/2008US20080214534 (1,10B-Dihydro-2-(Aminoalkyl-Phenyl)-5H-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
09/04/2008CA2679429A1 Inhibitors of serine proteases for the treatment of hcv infections
09/04/2008CA2679426A1 Inhibitors of serine proteases
09/03/2008EP1963334A1 Chromone derivatives useful as antagonists of vr1 receptors
09/03/2008EP1670840B1 Process for making amide acetals
09/03/2008EP1262477B1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
09/03/2008CN101258155A Tetracyclic indole derivatives as antiviral agents
09/03/2008CN101257948A Pyrimidine-fused diazepine derivatives and indole-fused pteridines
09/03/2008CN101255170A 2,3-dihydroimidazo[2,1-b]oxazole compound
09/03/2008CN100415753C 4-dimethylamino crotonic acid, its derivatives and their preparing method
09/03/2008CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one
09/02/2008US7420065 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
09/02/2008US7420062 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
09/02/2008US7420059 HMG-CoA reductase inhibitors and method
09/02/2008US7420054 Leucine-9-aminobenzo[a]phenoxazin-5-one; use thereof for the detection and/or identification and/or quantification of microorganisms expressing at least one peptidase activity, microbiology, biochemistry, immunology, molecular biology, histology
09/02/2008US7419969 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide
08/2008
08/28/2008WO2008102749A1 Heterocyclic compound
08/28/2008WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008US20080207900 Two cyclic oxomorphorin derivatives
08/28/2008US20080207899 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
08/28/2008CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/27/2008EP1960406A2 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
08/27/2008EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/27/2008CN101253180A 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
08/27/2008CN101253171A Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
08/27/2008CN101250208A L-nucleic acid derivative and processes for the synthesis thereof
08/27/2008CN101250194A L-nucleic acid derivative and processes for the synthesis thereof
08/27/2008CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
08/26/2008US7417145 Process for total synthesis of ecteinascidins and intermediates therefor
08/26/2008US7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
08/26/2008US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring
08/26/2008US7416724 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2343880C Polyketide synthase enzymes and recombinant dna constructs therefor
08/21/2008WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008WO2008099883A1 Therapeutic agent for liver cancer
08/21/2008WO2008075148A3 Tricyclic inhibitors of carbonic anhydrase
08/21/2008WO2007092641A3 Method for substituted 1h-imidazo[4,5-c]pyridines
08/21/2008US20080200674 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents;Alzheimer's disease; anticancer agents
08/21/2008US20080200673 Process for The Preparation of Sulfonic Acid Salts of Oxabispidines
08/21/2008US20080200336 Substituted 3-hydroxy-4-aryl-5-oxopyrazoline herbicides, and safeners such as N-[4-(2-methoxybenzoylsulfamoyl)phenyl]amides; cereal, maize and sorghum crops
08/21/2008CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/20/2008EP1957501A2 Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
08/20/2008EP1957500A1 Process for the preparation of purified crystalline cci-779
08/20/2008EP1957499A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
08/20/2008EP1957475A1 Chromenones and their use as modulators of metabotropic glutamate receptors
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1745052B1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
08/20/2008EP1485369B1 Blue 3h-naphtho- 2,1-b -pyran derivatives and use thereof
08/20/2008CN101248074A Xanthine oxidase inhibitor
08/20/2008CN101248070A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
08/20/2008CN101248067A Oxazolidinone derivatives and use thereof as antibiotics
08/20/2008CN101245074A Novel method for preparing fenspiride
08/20/2008CN100412076C New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
08/20/2008CN100412075C Process for preparing L-ofloxacin and ofloxacin
08/19/2008US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging
08/19/2008US7414132 prophylaxis and treatment of obesity; secondary amines such as 6-{4-[(3-Methyl-butylamino)-methyl]-phenoxy}-nicotinimidic acid ethyl ester
08/19/2008US7414129 Reactive triphendioxazine dyes, methods for the production thereof, and use thereof
08/19/2008US7414066 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders
08/19/2008US7414052 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
08/19/2008US7414051 8-(4-Methylpiperazin-1-yl)-6-(1-naphthylsulfonyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]-indazole; antidepressant, anxiolytic agent, cognition activator;
08/19/2008US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
08/19/2008US7414046 Gyrase inhibitors and uses thereof
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
08/14/2008WO2008096746A1 Spiro compound and use thereof
08/14/2008WO2008096001A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008WO2008007210A3 Nitrogenous n-substituted 4-spiro-heterocyclic 2, 2 -dimethylchromane derivatives
08/14/2008US20080194558 Quinazoline analogs as receptor Tyrosine Kinase inhibitors
08/14/2008US20080194547 6-{[(3-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.1.0]hex-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 220